Browse by Audience
Skip to content
Papers of the Week
Subcutaneous sumatriptan: association with decreases in postoperative pain and opioid use after elective cranial surgery.
Abstract
Sumatriptan, a serotonin receptor agonist, has been used in the management of primary headache disorders and has been shown to affect trigeminal dural afferents. There is limited literature on the safety and efficacy of sumatriptan for postcraniotomy pain management. This study aimed to identify whether subcutaneous sumatriptan is a safe and efficacious pain management strategy after elective craniotomy.